CD20-specific chimeric antigen receptor-expressing T cells as salvage therapy in rituximab-refractory/relapsed B-cell non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD20-specific chimeric antigen receptor-expressing T cells as salvage therapy in rituximab-refractory/relapsed B-cell non-Hodgkin lymphoma

Published:2022-10 Issue:10 Volume:24 Page:1026-1034
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Cheng Qian^ORCID,Tan Jingwen,Liu Rui,Kang Liqing,Zhang Yi,Wang Erhua,Li Ying,Zhang Jian,Xiao Han,Xu Nan^ORCID,Li Minghao^ORCID,Yu Lei,Li Xin

Funder

Natural Science Foundation of Hunan Province

Xiangya Hospital, Central South University

National Natural Science Foundation of China

Central South University

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference28 articles.

1. Anti-CD20 treatment for B-cell malignancies: current status and future directions;Klein;Expert Opin Biol Ther,2021

2. Novel immunotherapies in lymphoid malignancies;Batlevi;Nat Rev Clin Oncol,2016

3. Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia;Meinhardt;J Clin Oncol,2010

4. Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure;Ayers;Cancer Am Cancer Soc,2020

5. Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma;Lin;J Clin Oncol,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177- radiopharmaceuticals based on antibodies;Journal of Drug Delivery Science and Technology;2024-10

2. Bayesian network analysis of risk classification strategies in the regulation of cellular products;Artificial Intelligence in Medicine;2024-09

3. A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023;Human Vaccines & Immunotherapeutics;2024-07-03

4. Cytokine release syndrome after chimeric antigen receptor T cell therapy in patients with diffuse large B-cell lymphoma: a systematic review;Hematology, Transfusion and Cell Therapy;2024-07

5. CD20 CAR T cells safely and reversibly ablate B cell follicles in a non-human primate model of HIV persistence;Molecular Therapy;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3